Bispecific binding agents binding to CLDN18.2 and CD3
The present invention provides binding agents comprising at least two binding domains, wherein a first binding domain has specificity for CLDN18.2 and a second binding domain has specificity for CD3, and methods of using these binding agents or nucleic acids encoding therefor for treating cancer.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
29.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides binding agents comprising at least two binding domains, wherein a first binding domain has specificity for CLDN18.2 and a second binding domain has specificity for CD3, and methods of using these binding agents or nucleic acids encoding therefor for treating cancer. |
---|---|
AbstractList | The present invention provides binding agents comprising at least two binding domains, wherein a first binding domain has specificity for CLDN18.2 and a second binding domain has specificity for CD3, and methods of using these binding agents or nucleic acids encoding therefor for treating cancer. |
Author | Nisthal, Alex Moore, Gregory Bernett, Matthew |
Author_xml | – fullname: Bernett, Matthew – fullname: Moore, Gregory – fullname: Nisthal, Alex |
BookMark | eNrjYmDJy89L5WQwdcosLkhNzkzLTFZIysxLycxLV0hMT80rKYZzS_IVnH1c_Awt9IwUEvNSFJxdjHkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGhubGloYmpk5ExMWoAjYgszw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US11739145B2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US11739145B23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 10:31:55 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US11739145B23 |
Notes | Application Number: US202218062465 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230829&DB=EPODOC&CC=US&NR=11739145B2 |
ParticipantIDs | epo_espacenet_US11739145B2 |
PublicationCentury | 2000 |
PublicationDate | 20230829 |
PublicationDateYYYYMMDD | 2023-08-29 |
PublicationDate_xml | – month: 08 year: 2023 text: 20230829 day: 29 |
PublicationDecade | 2020 |
PublicationYear | 2023 |
RelatedCompanies | Astellas Pharma Europe BV Xencor, Inc |
RelatedCompanies_xml | – name: Astellas Pharma Europe BV – name: Xencor, Inc |
Score | 3.4947634 |
Snippet | The present invention provides binding agents comprising at least two binding domains, wherein a first binding domain has specificity for CLDN18.2 and a second... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | Bispecific binding agents binding to CLDN18.2 and CD3 |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230829&DB=EPODOC&locale=&CC=US&NR=11739145B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6LzgwrSt2qbpB95KELTliGuG26VvY22a6B7aIet-O-blG7zRd_yAZfk4O6Su_tdAB4zPbeoQzItoSjRCKFIo5xwTV-ZOLcs27apBAqPI2sUk9eFuejBeouFaeuEfrfFEYVEZULem1Zfb_ZOLL_Nrayf00IMVS_h3PXV7nWMZPEVqvqeG0wn_oSpjLnxTI3eXcOwMTWI6Ql1fSCv0bLOfvDhSVTK5rdJCU_hcCqolc0Z9PJyAMds-_PaAI7GXcBbNDvZq8_B9AoJi5SpPUpatGAUJZHAqHrXbSqFvfmR4TwhJSlXCvPxBTyEwZyNNLH-cnfYZTzbbxVfQr-syvwKFGNlcUdHicVtwUoZruOI59hxeJalOibXMPybzvC_yRs4kYyTflJEb6HffH7ld8LQNul9y6EfotmAAw |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq6L1FUFyiyabzWMPQcimoWqbFttKbyWvhXhIion4991d-vCit33A7O7AzDCPbxbgPtVzm7g41WKCYg1jgjTCMNP0zDJz23Ychwig8CiyB3P8srAWLfjYYGFkn9Bv2RyRS1TK5b2R-nq1C2IFsrayfkwKvlQ9hTMvUNfeMRLNV4ga-F5_Mg7GVKXUm0_V6M0zDMckBrZ8rq73HO4SSlfp3ReolNVvkxIewf6EUyubY2jlZRc6dPPzWhcORuuENx-uZa8-AcsvBCxSlPYoSSHBKEosgFH1dtpUCh0GkeE-ICUuM4UG5inchf0ZHWj8_OX2scv5dHdV8wzaZVXm56AYmc1cHcU2czgrRbqOIZabrsvSNNFNfAG9v-n0_tu8hc5gNhouh8_R6yUcCiaKmCkiV9BuPr_ya250m-RGcusHw7uC7Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Bispecific+binding+agents+binding+to+CLDN18.2+and+CD3&rft.inventor=Bernett%2C+Matthew&rft.inventor=Moore%2C+Gregory&rft.inventor=Nisthal%2C+Alex&rft.date=2023-08-29&rft.externalDBID=B2&rft.externalDocID=US11739145B2 |